SCL Science Inc.
Founded in 2010 and KOSDAQ-listed in 2019, SCL Science operates medical sealant, bio-logistics, and data platform businesses.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in April 2010 and listed on KOSDAQ in February 2019, SCL Science is a medical device company operating a medical sealant business built on hemostasis and sealing protein-binding platforms, a bio-logistics business, and a data platform business. Its hemostasis platform products include InnoSEAL, InnoLOCK, InTro, and InnoSEAL Plus DL, while its data platform business offers the AI imaging-reading solution HiImage and the health-checkup management solution MyOneCare. Consolidated revenue for the 16th fiscal term (2025) reached KRW 22,011 million, up 365% from KRW 4,737 million the prior year, driven mainly by the consolidation of wholly owned subsidiary SCL Healthcare (acquired March 2025) and the medical diagnostics business unit (acquired July 2025).
Products & technology
- InnoSEAL Hemostatic PadTopical hemostatic dressing used in vascular intervention procedures
- InnoLOCK Hemostasis ValveNon-implantable vascular access device
- InnoSEAL Radial Band2Hemostasis band/tourniquet
- InTroIntravascular guiding catheter
- InnoSEAL Plus DLAbsorbable internal hemostatic agent used for hemostasis in intra-abdominal surgeries such as liver resection
- HiImageAI-based solution supporting physicians in reading X-ray and CT images
- MyOneCareIntegrated health checkup management solution
- Bio-logistics serviceIoT-based cold-chain transport service for temperature/time-sensitive human-derived materials, biological products, pharmaceuticals, and medical devices
Regulatory approvals
data.go.kr10 Korean MFDS device approvals · 2015–2025
- MFDSDressing, collagen, wound2025-05-28Product approval · Class 3제허 25-354 호
- MFDSHemostat, internal, absorbable2025-02-03Product approval · Class 4제허 25-61 호
- MFDSIntravascular guiding catheter2024-05-29Product approval · Class 2제인 24-536 호
- MFDSDressing, topical hemostasis, external2022-11-23Product approval · Class 2제인 22-4906 호
- MFDSHemostat, internal, absorbable2022-03-28Product approval · Class 4제허 22-210 호
- MFDSDressing, topical hemostasis, externalRevoked2022-01-13Product approval · Class 2제인 22-4019 호
- MFDSTourniquet strapRevoked2020-07-31Product approval · Class 1제신 20-1164 호
- MFDSHemostat, internal, absorbable2019-12-24Product approval · Class 4제허 19-832 호
- MFDSHemostat, internal, absorbable2019-10-08Product approval · Class 4제허 19-633 호
- MFDSDressing, topical hemostasis, external2015-03-04Product approval · Class 2제인 15-311 호
R&D and key agreements
Source: DART corporate disclosure밀폐 플랫폼 · 각종 천공 부위의 체액 누출 방지 · 개발 중 · Developing a sealing platform to prevent fluid leakage from various perforation sites.
AI reads
MAA server logs · IP-verifiedSomeone asked an AI a question, and it fetched this page live to answer.
Collected for later use. Not a signal of interest.
- OpenAIOAI-SearchBot1
Measured since Aug 25, 2026 · 1 AI engines · last read Aug 25, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSPI-listed operating holding company of the Hanmi Pharm group, also running healthcare and pharmaceutical wholesale businesses.
KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.
Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.
Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.
Founded in 2004 and listed on KOSDAQ in 2011, NIBEC develops dental tissue regeneration biomaterials and peptide-based biomaterials.
Founded and KOSPI-listed in 2025, Samyang Biopharm develops medical devices, pharmaceuticals, and new drug candidates.
Founded in 2013 and KOSDAQ-listed in 2018, T&R Biofab commercializes 3D bioprinting systems, bioinks, and biodegradable scaffolds.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.
Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.
Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition